Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation CADTH. Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Reference List. 2013 Authors' conclusions One evidence-based guideline was identified for the use of naloxone to reverse the effects of narcotics in long-term care and palliative care patients. No evidence was identified regarding the clinical effectiveness and safety of naloxone to reverse the effects of narcotics in long-term care and palliative care patients. Indexing Status Subject indexing assigned by CRD MeSH Humans; Naloxone; Palliative Care Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32014000855 Date abstract record published 17/07/2014 |